Ferro-Folgamma® (Ferro-Folgamma®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceIron sulphate + Folic acid + CyanocobalaminIron sulphate + Folic acid + Cyanocobalamin
Similar drugsTo uncover
  • Ferro-Folgamma®
    capsules inwards 
    Wörwag Pharma GmbH & Co. KG. KG     Germany
    • Dosage form: & nbspCapsules.
    Composition:

    One capsule contains:

    active substances: iron sulfate 112.6 mg (equivalent to 37 mg of iron ion), folic acid 5 mg, cyanocobalamin 0.010 mg,

    Excipients: ascorbic acid, hard fat, rapeseed oil, soy lecithin, gelatin, sorbitol solution 70%, glycerol, iron oxide red (E 172), iron oxide black (E 172), ethyl vanillin.

    Description:

    Soft gelatin capsules of oblong form with a two-color longitudinal coating of the halves of the shell in light and dark brown color.

    Pharmacotherapeutic group:Iron preparation + multivitamins.
    ATX: & nbsp

    B.03.A.E.01   Preparations of iron in combination with vitamin B12 and folic acid

    Pharmacodynamics:

    Ferro-Folgamma® is a complex anti-anemic drug containing ferrous iron in the form of a simple ferric sulfate salt, vitamins B12, folic and ascorbic acid, designed to treat iron deficiency conditions. Iron is an important part of the human body. It is part of hemoglobin, myoglobin and various other enzymes. Ascorbic acid improves absorption of iron in the intestine. Vitamins B12 and folic acid participate in the formation and maturation of red blood cells.

    The active components of the Ferro-Folgam® preparation are in a special neutral shell, which ensures their absorption, mainly in the upper part of the small intestine. The absence of a local irritant effect on the gastric mucosa promotes good tolerance of the drug from the gastrointestinal tract.

    Indications:

    Combined iron-folic-B12-deficit anemia caused by chronic blood loss (gastric, intestinal bleeding, bleeding from the bladder, hemorrhoids, menopoietic rhabdomy), as well as chronic alcoholism, infections, taking anticonvulsant and oral contraceptives; anemia during pregnancy and lactation.

    Prevention of iron and folate deficiency in the second and third trimesters of pregnancy, in the postpartum period, during lactation.

    Contraindications:

    Anemia not caused by iron deficiency (eg, hemolytic anemia or isolated megaloblastic anemia caused by a deficiency of vitamin B12), hypersensitivity, liver failure.

    Excessive iron content in the body (eg, hemosiderosis, hemochromatosis).

    Disorder of iron utilization mechanisms (eg, lead anemia, sidero-achestic anemia).

    Dosing and Administration:

    Inside for 1-2 capsules after eating.

    Anemia: light form 1 capsule 3 times a day for 3-4 weeks; with medium-heavy flow - 1 capsule 3 times a day for 8-12 weeks; in severe form - 2 capsules 3 times a day, for 16 weeks or more.

    During pregnancy - for the prevention of a deficiency of folic acid and iron - 1 capsule 3 times a day in 2 and 3 trimesters, in the postpartum period during lactation.

    Side effects:

    Nausea, allergic reactions: eczematous phenomena, urticaria, anaphylactic shock, anaphylactoid reactions.

    Overdose:

    It is characterized by the appearance of epigastric pains, nausea, vomiting, stools, drowsiness, pallor, the development of a shock state up to coma. Recommended treatment measures include gastric lavage, desferroxamine administration and the organization of adequate maintenance therapy.

    Interaction:

    Organic acids, calcium salts, phosphates, phytin, cholestyramine, as well as antacid preparations containing aluminum, magnesium, calcium, interfere with iron absorption due to the formation of insoluble complexes. Preparations containing pancreatic enzymes can reduce iron absorption.

    With the simultaneous use of phenobarbital, carbamazepine, valproate, sulfasalazine, hormonal contraceptives, antagonists of folic acid, trimethoprim, pyrimethamine and triamterone, the absorption of folic acid decreases.

    Iron salts disrupt absorption in the gastrointestinal tract of antibiotics of the tetracycline group.

    Solid food, bread, raw cereals, dairy products, eggs reduce the absorption of iron, with the simultaneous administration of tetracycline with antibiotics, as well as with penicillinamine, complex compounds are formed that reduce the absorption of iron and reduce the antimicrobial activity of antibiotics.

    Special instructions:

    The dark color of the stool is due to the excretion of non-absorbed iron and has no clinical significance.

    Form release / dosage:

    Capsules.

    10 capsules per blister, made of polyvinyl chloride film and aluminum foil.

    For 2 or 5 blisters together with instructions for use in a cardboard bundle.

    Packaging:

    Capsules.

    10 capsules per blister, made of polyvinyl chloride film and aluminum foil.

    For 2 or 5 blisters together with instructions for use in a cardboard bundle.

    Storage conditions:

    At a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:2 years.

    Do not use after the period indicated on the vpacking.

    Terms of leave from pharmacies:On prescription
    Registration number:П N012666 / 01
    Date of registration:19.08.2011
    The owner of the registration certificate:Wörwag Pharma GmbH & Co. KG. KGWörwag Pharma GmbH & Co. KG. KG Germany
    Manufacturer: & nbsp
    Representation: & nbspVEVWAG PHARMA GmbH & Co. KG VEVWAG PHARMA GmbH & Co. KG Germany
    Information update date: & nbsp29.12.2014
    Illustrated instructions
      Instructions
      Up